ArticleRheumatology and therapy2018

Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs in United States and Rest of World: A Subset Analysis.

Alvin F Wells et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.